Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines By Reuters

FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines…

Lisata (LSTA) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEThursday, Nov. 6, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Dr. David…

AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform

AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso, Imfinzi and Farxiga fuel…

AstraZeneca climbs to new high after US deal reassurance

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, where guidance was maintained and the…

AstraZeneca climbs to net all-time high after US deal reassurance

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, but the shares barely moved in…

Astrazeneca: Starkes Quartal dank Krebsarzneien und gute Aussichten für 2026

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat ein weiteres überraschend starkes Quartal hinter sich. In den drei Monaten bis…

AstraZeneca beats forecasts in Q3, reaffirms full-year guidance By Investing.com

AstraZeneca beats forecasts in Q3, reaffirms full-year guidance…

AstraZeneca grows faster than expected but maintains guidance

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted a confident set of third-quarter results, not only beating revenue and core earnings forecasts, but also...…

FTSE 100 Live: Blue-chips slide as Smith & Nephew disappoints, Bank of England holds

FTSE 100 falls 20 points to 9,757 Bank of England decision due at midday AstraZeneca beats forecasts but shares little-moved Towering…

AstraZeneca beats third-quarter revenue and profit expectations

AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of key cancer, heart and kidney disease drugs, prompting…

Halozyme (HALO) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEMonday, Nov. 3, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Helen TorleySenior…

AstraZeneca wins shareholder backing for NYSE listing in US pivot

AstraZeneca shareholders approved a direct listing of the drugmakers shares on the New York Stock Exchange on Monday, giving it…

AstraZeneca wins shareholder backing for NYSE listing as drugmaker pivots to US

AstraZeneca shareholders approved a direct listing of the drugmakers shares on the New York Stock Exchange on Monday, giving it…

Result of General Meeting

3 November 2025Result of General Meeting held on 3 November 2025AstraZeneca PLC (the Company) announced that at the General Meeting…

AstraZeneca to face questions on Trump MFN deal, patent expiries and pipeline

When AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) reports third-quarter results next Thursday, 6 November, with investors and analysts will be keen to hear about...…

Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors

Astrazeneca (AZN) closed at $82.61 in the latest trading session, marking a -1.72% move from the prior day.…

Pipeline power keeps AstraZeneca in rude health

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is looking more marathon runner than sprinter these days. The pharmaceuticals giant has spent years building…

IRW-News: ACCESS Newswire: Führende Fortune-500-Unternehmen berichten im Rahmen einer OMP-Konferenz über KI-Kompetenzen zur Stärkung der Lieferkette

IRW-PRESS: ACCESS Newswire: Führende Fortune-500-Unternehmen berichten im Rahmen einer OMP-Konferenz über KI-Kompetenzen zur Stärkung der LieferketteBranchenriesen wie AstraZeneca, Johnson &…

Top Research Reports for AstraZeneca, RTX & Applied Materials

AstraZeneca, RTX, and Applied Materials stand out in todays Zacks Research Daily with strong performance drivers and key growth catalysts.…

Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Astrazeneca (AZN) closed at $84.69, marking a +1.03% move from the previous day.…

What Pfizer And AstraZeneca’s Deals With The Trump Administration Mean For Pharma

With the administration’s aggressive tactics, pharmaceutical companies cannot avoid this reckoning, but they can shape how it unfolds.…

AstraZeneca downgraded by leading investment bank. Heres why

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) investors might want to take a deep breath. Deutsche Bank has turned bearish on the UK…

AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve

AstraZeneca secures a three-year tariff break after striking a landmark U.S. deal to cut drug prices and expand its domestic…

FIVE AT FIVE: Lloyds takes further £800m hit as AZ nails down deal with Trump administration

A lively start to the week, with Lloyds digging deeper into its pockets, AstraZeneca bowing to US price pressures, and…

AstraZenecas drug pricing deal with Trump far from clear result, say analysts

Following AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) agreement with the US government on most favoured nation drug pricing at the end of last week,...…

AstraZeneca unter Strom! Preisdeal, Investitionen für 50 Mrd. USD und klinischer Rückenwind!

AstraZeneca (AZN) trotzt dem Gegenwind in der Pharmabranche. Mit einem historischen Preisdeal in den USA, milliardenschweren Investitionen in heimische US-Produktion…

AstraZeneca strikes deal with US to lower drug prices

AstraZeneca has announced an agreement with the Trump administration to dramatically reduce prescription medicine costs for American patients while preserving…

AstraZeneca agrees to offer US discounts in exchange for no tariffs

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has become the second giant drugmaker to announce a drug pricing deal with the US government, after Pfizers…

FTSE 100 Live: Miners and Lloyds lead index gains, defence stocks on the slide

FTSE 100 up 6 points to 9,434 Lloyds rises after confirming extra provisions AstraZeneca little moved after US drug pricing…

dpa-AFX-Überblick: UNTERNEHMEN - Die wichtigsten Meldungen vom Wochenende

Deal mit Trump: Astrazeneca bekommt Zollnachlass für Preissenkungen in USA WASHINGTON - Der britische Pharmakonzern Astrazeneca …

Deal mit Trump: Astrazeneca bekommt Zollnachlass für Preissenkungen in USA

WASHINGTON (dpa-AFX) - Der britische Pharmakonzern Astrazeneca hat sich mit US-Präsident Donald Trump auf Preissenkungen bei einigen Medikamenten im…

Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump

AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a…

Donald Trump: AstraZeneca und USA einigen sich auf Vereinbarung zu Medikamentenpreisen

Donald Trump drängt Pharmakonzerne, ihre Preise zu reduzieren. Nun hat sich mit AstraZeneca ein zweites Unternehmen auf eine Vereinbarung eingelassen.…

Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports

Trump is set to announce the agreement with AstraZeneca on Friday, after striking a similar deal with Pfizer late last…

Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly

Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after…

AstraZeneca: 4,5 Mrd. USD-Produktionsoffensive in den USA, Onkologie-Pipeline, Preisdruck - was überwiegt?

Bad Marienberg (www.aktiencheck.de) - ???? Executive Summary: Produktionsoffensive in den USA, intakte Wachstumsnarrative, Kurs 148,15 EUR (-0,37 %)AstraZeneca hat in…

AstraZeneca to invest $4.5 billion in Virginia manufacturing facility By Investing.com

AstraZeneca to invest $4.5 billion in Virginia manufacturing facility…

AstraZeneca breaks ground at $4.5 billion Virginia plant as drugmakers court Trump

AstraZeneca broke ground on a new plant in Virginia on Thursday and said it would spend $4.5 billion on the…

AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs

WILMINGTON, Del., October 09, 2025--AstraZeneca today announces that it will invest $4.5 billion in its new manufacturing facility in Virginia,…

dpa-AFX ProFeed